Hello, and thanks for stopping by! My career in the financial services industry spans 35 plus years and encompasses all aspects of life sciences capital markets. More specifically, I have deep experience, knowledge, and relationships in assisting drug, device, and medical informatics emerging ...more

Hello, and thanks for stopping by! My career in the financial services industry spans 35 plus years and encompasses all aspects of life sciences capital markets. More specifically, I have deep experience, knowledge, and relationships in assisting drug, device, and medical informatics emerging growth companies in navigating the complex process of listing on senior global stock exchanges and securing transformational capital. I previously served as the President of The Giordano Group Inc. a Division of Network 1 Financial Securities, a boutique Capital Markets Advisory Firm in the life science sector, and was licensed as an Investment Banker with Network 1 Financial Securities. During this time I also served as an associate of Launchpad Inc, a capital markets advisory firm with extensive expertise and activity in the life sciences industry. I have also had the honor of serving in KCSA Worldwide, a middle market Investors Relations firm for seven years, ending in 2001, after which, I founded my own boutique investor relations firm, ROI Group, with an emphasis on supporting early-stage, emerging companies, principally in the life sciences sector. My firm regularly arranged Capital introductory opportunities for our clients to life science-oriented investment banks. When I sold that firm in 2007, as a natural extension of this activity, I then joined Jesup and Lamont as Managing Director of its life science banking practice. I hold a B.A. from St. John's University, an L.L.B. from St. John's Law School, and a Series 7 Securities License. As a result of the separate but related experiences in life sciences investment banking and investor relations, I have developed a unique skill set in providing programs that seamlessly integrate both disciplines on behalf of early-stage life science companies. Now, as the Managing Director of the Exchange Listing, Life Sciences Group I am bringing my team, experience, and resources to assist emerging Life Science growth companies interested in exploring an IPO/senior exchange listing as a means to accelerate their business objectives. Is this your company? Let’s connect!less